Day: September 16, 2024

Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Cambridge, MA, Sept. 16, 2024 (GLOBE NEWSWIRE) — The unprecedented 2020-2024 interest rate cycle marked the fastest pivot from an active easing to tightening by policymakers in advanced economies since the 1970s. What followed was the most globally synchronized, aggressive rate tightening in the last 55 years — and it was also the longest period policymakers held rates at their peaks. 

Even if the Federal Reserve pivots to cutting interest rates, rates may not fall to levels typical of the last 15 years during this rate cycle. This would leave consumers and businesses in a world of higher rates, sending a ripple effect throughout the U.S. economy, and prompting more difficult tradeoffs, suggests a new paper “Rate Cycles” by MIT Sloan School of Management professor of global economics and management Kristin Forbes and colleagues.

Presented at the European Central Bank’s (ECB) annual Forum on Central Banking in Sintra, Portugal, in July, the findings have implications for policymakers and investors alike. A week before the Federal Reserve’s latest monetary policy meeting, investors expect policymakers to cut interest rates for the first time in four years, lowering them from their 23-year high as inflation eases. Based on the Fed’s latest projections, some anticipate that rates will drift lower from there, eventually settling in at around 2.5% to 3%. But rates may also not fall that much. 

“It’s not clear that rates need to fall to pre-2008 levels, even if the market is expecting them to,” Forbes said. “If so, we’re going to have to adjust to a world of higher interest rates, and it may be painful. There could be a big reckoning.” 

Along with Jongrim Ha and Ayhan Kose from the World Bank, Forbes analyzed cycles in interest rates in 24 advanced economies from 1970 to 2024, looking at how rate cycles have evolved over time. The paper and its findings are novel because, while many researchers have dissected business cycles, Forbes believes they are the first to apply an in-depth business cycle analysis to interest rate cycles. 

The researchers found that after the recent unprecedented swings in economic activity and aggressive central bank responses, growth and labor markets now seem to be stabilizing despite interest rates remaining at high levels not seen since before the 2008 financial crisis.

If rates do remain high, homeowners looking to sell, but holding out for cheaper rates, may find it more difficult to relocate. Companies that financed debt when interest rates were lower would pay more as they refinance. The federal government, for its part, is already paying substantially more interest on its debt, and it’s an expense that will only grow as deficits show no signs of abating. To compensate, taxes might go up, or federal spending fall — or both.

At the same time, rates at higher levels can provide some benefits to the economy if it makes consumers and businesses borrow more efficiently. People may be more cautious to take on debt, only borrowing if they’re confident about the return on investment. Younger Americans might have a harder time getting student loans or buying a home, but older ones with savings would benefit from higher rates. Overall, Americans might save more.

The researchers also discovered that during the 2020-2024 interest rate cycle, the impact of global shocks was not only bigger than home-grown factors, but had their largest impact on rates since the 1970s. This makes it even more challenging for central bankers who focus on stabilizing prices at home. Part of the shocks were well-documented global supply shocks, including supply chain disruptions around the pandemic and a spike in food and energy prices after Russia invaded Ukraine in 2022.

Forbes and her colleagues found that global demand shocks were also significant, yet they were largely underappreciated. Consumers who had saved their money and were ready to spend found that supply was lagging behind. In the coming years, policymakers will increasingly find themselves responding to global shocks, and distinguishing between supply and demand shocks will be critical, Forbes said. 

“Policymakers will need to go one step further and not assume that they’re dealing with a global supply shock just because it originates outside their borders,” she said. “It could very well be a global demand shock, and there’s a very different response for each.”

With supply shocks, policymakers usually don’t need to raise interest rates as much in response, according to the researchers. On the other hand, they should respond more forcefully when they encounter demand-driven shocks. Teasing apart global and domestic forces as the drivers of shocks in individual economies is crucial, too, and the researchers discovered that supply shocks play a much greater role in the Euro area than they do in the United States.

Going forward, central bankers need to fully commit themselves to looking at multiple models as they set interest rates. “They need to look at a range of prices and be open to a variety of explanations and risks as they conduct monetary policy,” Forbes said, especially as she sees the current cycle as a cautionary tale. “Just because central banks’ strategy of starting late and then acting aggressively worked this time, it does not necessarily mean it will work in the future.”

• The unprecedented 2020-2024 interest rate cycle marked the fastest pivot from an active easing to tightening by policymakers in advanced economies since the 1970s.

Matthew Aliberti
MIT Sloan School of Management
7815583436
malib@mit.edu

Rockville, MD, Sept. 16, 2024 (GLOBE NEWSWIRE) — As stated in the recently updated report by Fact.MR, a market research and competitive intelligence provider, the global multiphoton microscopy market is evaluated to reach US$ 198.9 million in 2024, and the market is further projected to progress at a CAGR of 5.5% between 2024 and 2034. 

Strong imaging methods such as multiphoton microscopy are becoming more popular all over the world because of their growing use in several scientific fields. The need for this cutting-edge approach is rising in a variety of sectors, including materials science and neurology, as it provides researchers with previously unattainable insights into living tissues and materials. 

The method is essential to biomedical research because it produces three-dimensional and high-resolution photographs of deep tissue structures with little harm. Its increasing use is mostly due to its applicability in stem cell research, cancer research, and medication development. 

Multiphoton microscopes are now more widely used in laboratories worldwide due to technical improvements that have improved their accessibility and use. The appeal of this approach is further enhanced by its ability to observe biological processes over an extended period and its compatibility with several other imaging modalities. The widespread use of technology in academics with constant commercial development and rising funding is securing a position as a pivotal tool in contemporary scientific inquiry. 

For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=3405

Key Takeaways from Market Study:

• The global multiphoton microscopy market is forecasted to reach US$ 339.7 million by the end of 2034. 

• In the East Asian region, the market in Japan is analyzed to advance at a CAGR of 6% between 2024 and 2034. 

• East Asia is evaluated to hold a share of 22.4% in 2024 with a valuation of US$ 44.5 million in 2024. 

• The market in Canada in North America is approximated to advance at a CAGR of 6% through 2034. 

• Among different end users of multiphoton microscopy, hospitals and clinics are estimated to hold a share of 33.8% in 2024. 

“The ability to image living specimens for extended periods is helping doctors to study organisms, which is driving demand for multiphoton microscopy in the medical field,” says a Fact.MR analyst. 

Leading Players Driving Innovation in Multiphoton Microscopy Market:

Sutter Instrument; Olympus Corporation; Bruker; Leica Microsystems (Danhar); Femtonics Ltd.; Nikon; ZEISS; Lavision Biotech; Thorlabs, Inc; Semrock; Scientifica (Judges Scientific plc); Becker & Hickl GmbH.

Development of Small and Portable Multiphoton Microscopy Increasing Convenience in Studies Anywhere and Anytime:

The depth and speed of imaging have been greatly increased by the introduction of femtosecond lasers that are more steady and strong. Tissue-induced aberrations are currently being compensated for by novel adaptive optics systems, significantly improving picture quality in thick specimens. 

Real-time 3D reconstructions and automatic feature recognition are possible by the revolutionary advancement of image processing and analysis through the integration of artificial intelligence and machine learning algorithms. Furthermore, the development of multicolor multiphoton imaging systems makes it possible to visualize several cellular components at once, increasing the technique’s usefulness in intricate biological research. 

The development of small, portable multiphoton microscopes due to miniaturization efforts has made in-vivo imaging possible in therapeutic settings. Researchers from a wide range of fields are now more easily utilizing multiphoton microscopy with these advancements, automation, and enhanced user interfaces. Multiphoton microscopy is becoming an increasingly important tool for cutting-edge research in the scientific community worldwide as these technical breakthroughs push the frontiers of biological imaging.  

Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=S&rep_id=3405

Multiphoton Microscopy Industry News:

• In March 2022, Bruker unveiled the Ultima Investigator Plus, a brand-new modular platform made specifically for deep tissue fluorescence imaging with the Ultima line of multiphoton microscopes.
• The AXE R MP multiphoton confocal microscope, developed by high-tech microscopy system pioneer Nikon Instruments Inc., was released in December 2021. It can take fast, accurate, high-quality, wide-angle photographs at a high speed while residing deep within living organisms.

More Valuable Insights on Offer:

Fact.MR, in its new offering, presents an unbiased analysis of the multiphoton microscopy market for 2019 to 2023 and forecast statistics for 2024 to 2034. 

The study divulges essential insights into the market based on product (two photon microscopy, three photon microscopy), by application (skin imaging, neuroscience, oncology, immunology, deep tissue imaging, functional & molecular imaging, intravital imaging, cell culture, virology), end user (hospitals & clinics, clinical & diagnostics laboratories, academic & research institutes), across seven major regions of the world (North America, Western Europe, Eastern Europe, East Asia, Latin America, South Asia & Pacific, and MEA). 

Check out More Related Studies Published by Fact.MR Research:

Microscopy Devices Market: stands at a value of US$ 9.9 billion in 2023 and is estimated to exhibit expansion at 6.9% CAGR over the next ten years. As such, worldwide microscopy device shipments are forecasted to reach US$ 19.3 billion by 2033-end.

Automated Microscopy Market: is forecasted to magnify at a CAGR of 7.2% and increase from a market valuation of US$ 6 billion in 2022 to US$ 8.5 billion by the end of 2027.

Acoustic Microscopy Market: is estimated at US$ 1.29 billion in 2023 and is projected to reach a market valuation of US$ 2.2 billion by 2033. The global demand for acoustic microscopy technologies is predicted to increase at a CAGR of 5.5% from 2023 to 2033.

Blood Cancer Diagnostics Market: reached a valuation of US$ 15.05 Billion, and is likely to register a Y-o-Y growth rate of 5.6% in 2022, closing at US$ 15.95 Billion. Furthermore, across the 2022-2032 period of assessment, growth is expected to accelerate at a whopping 6.0% CAGR, reaching US$ 28.57 Billion.

Lung Cancer Diagnostics Market: reaching a value of US$ 2.98 billion in 2024. The global lung cancer diagnostics market size has been projected to expand at a CAGR of 6.1% and end up at US$ 5.4 billion by 2034

About Us:

Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning.

With its unwavering dedication to providing reliable market intelligence, FACT.MR continues to assist companies in navigating dynamic market challenges with confidence and achieving long-term success. With a global presence and a team of experienced analysts, FACT.MR ensures its clients receive actionable insights to capitalize on emerging opportunities and stay competitive.

Follow Us: LinkedIn | Twitter | Blog

Contact:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Team: sales@factmr.com